問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
顏嘉德
下載
2018-05-01 - 2023-09-30
Condition/Disease
TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer
Test Drug
Keytruda injection
Participate Sites15Sites
Recruiting1Sites
Terminated13Sites
Division of Thoracic Medicine
2021-07-27 - 2025-06-30
Allergic Asthma
FB825
Participate Sites17Sites
Not yet recruiting5Sites
Recruiting12Sites
2020-09-15 - 2025-10-08
Non-Small Cell Lung Cancer (NSCLC)
Patritumab Deruxtecan (U3-1402)
Participate Sites8Sites
Recruiting8Sites
2015-02-25 - 2025-12-31
COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER
MEDI4736
Participate Sites13Sites
Not yet recruiting2Sites
Recruiting3Sites
Terminated8Sites
全部
